Given the crucial role of TREM2 in regulating both lipid metabolism and immune responses, therapeutic interventions targeting TREM2 modulation may offer promising novel strategies for the treatment of MASH (102). The gene discussed is TREM2; the disease is metabolic dysfunction-associated steatohepatitis.